首页> 美国卫生研究院文献>ACS AuthorChoice >Distributed Drug Discovery Part 2: Global Rehearsal of Alkylating Agents for the Synthesis of Resin-Bound Unnatural Amino Acids and Virtual D3 Catalog Construction
【2h】

Distributed Drug Discovery Part 2: Global Rehearsal of Alkylating Agents for the Synthesis of Resin-Bound Unnatural Amino Acids and Virtual D3 Catalog Construction

机译:分布式药物发现第2部分:用于树脂结合的非天然氨基酸合成的烷基化剂的全球演练和虚拟D3目录构建

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Distributed Drug Discovery (D3) proposes solving large drug discovery problems by breaking them into smaller units for processing at multiple sites. A key component of the synthetic and computational stages of D3 is the global rehearsal of prospective reagents and their subsequent use in the creation of virtual catalogs of molecules accessible by simple, inexpensive combinatorial chemistry. The first section of this article documents the feasibility of the synthetic component of Distributed Drug Discovery. Twenty-four alkylating agents were rehearsed in the United States, Poland, Russia, and Spain, for their utility in the synthesis of resin-bound unnatural amino acids >1, key intermediates in many combinatorial chemistry procedures. This global reagent rehearsal, coupled to virtual library generation, increases the likelihood that any member of that virtual library can be made. It facilitates the realistic integration of worldwide virtual D3 catalog computational analysis with synthesis. The second part of this article describes the creation of the first virtual D3 catalog. It reports the enumeration of 24 416 acylated unnatural amino acids >5, assembled from lists of either rehearsed or well-precedented alkylating and acylating reagents, and describes how the resulting catalog can be freely accessed, searched, and downloaded by the scientific community.
机译:分布式药物发现(D 3 )提出了将大型药物发现问题分解为较小的单元,以便在多个站点进行处理的方法。 D 3 的合成和计算阶段的关键组成部分是前瞻性试剂的全球排练及其在随后通过简单,廉价的组合化学方法获得的分子虚拟目录创建中的使用。本文的第一部分介绍了分布式药物发现合成组件的可行性。在美国,波兰,俄罗斯和西班牙,有24种烷基化剂被演练,原因是它们在合成树脂结合的非天然氨基酸> 1 中是有用的,而氨基酸是许多组合化学程序中的关键中间体。这种全局试剂排练,再加上虚拟库的生成,增加了可以制造该虚拟库的任何成员的可能性。它促进了全球虚拟D 3 目录计算分析与综合的现实集成。本文的第二部分描述了第一个虚拟D 3 目录的创建。它报告了从练或先验的烷基化和酰化试剂列表中汇总的24 416酰化非天然氨基酸> 5 的计数,并描述了如何免费访问,搜索和下载所得目录由科学界。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号